Insights From the informCLL Registry: Real-World Application of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

被引：0
|
作者：
Ghosh, Nilanjan [1 ]
Brander, Danielle [2 ]
Mato, Anthony R. [3 ]
Sharman, Jeff P. [4 ]
Gutierrez, Meghan [5 ]
Naganuma, Maoko [6 ]
Upasani, Sandhya [6 ]
Alagappan, Divi [7 ]
Huang, Qing [7 ]
Young, Alex [6 ]
Barrientos, Jacqueline C. [8 ]
机构：
[1] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
[2] Duke Univ Hlth Syst, Durham, NC USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Willamette Valley Canc Inst & Res Ctr, US Oncol Res, Eugene, OR USA
[5] Lymphoma Res Fdn, New York, NY USA
[6] Pharmacyclics LLC, Sunnyvale, CA USA
[7] Janssen Sci Affairs LLC, Horsham, PA USA
[8] Donald Barbara Zucker Sch Med Hofstra Northwell, Div Med Oncol & Hematol, Northwell Hlth Canc Inst, Lake Success, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
CLL; CLL/SLL; real-world; registry; del(17p); TP53;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-074
引用
收藏
页码：S317 / S317
页数：1
相关论文
共 50 条
  • [31] Real-World Outcomes of Patients Treated with Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Systematic Review and Meta-Analysis
    Cheung, Matthew C.
    Amitai, Irina
    BLOOD, 2020, 136
  • [32] Clinical Characteristics and Treatment Choices in Previously Untreated Elderly Patients (≥65 Years) With Chronic Lymphocytic Leukemia (CLL): Interim Analysis of the informCLL Real-World Registry
    Ghosh, Nilanjan
    Barrientos, Jacqueline C.
    Brander, Danielle
    Gutierrez, Meghan
    Ipe, David
    Iyengar, Reethi
    Arango-Hisijara, Israel
    He, Jinghua
    Huang, Qing
    Han, Jennifer
    Sharman, Jeff P.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S224 - S224
  • [33] TREATMENT AND PROGNOSTIC TESTING PATTERNS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: THE INFORMCLL™ REAL-WORLD REGISTRY INTERIM ANALYSIS
    Sundaram, M.
    Ghosh, N.
    Kadish, K.
    Upasani, S.
    Han, J.
    Amaya-Chanaga, C.
    Iyengar, R.
    VALUE IN HEALTH, 2020, 23 : S89 - S89
  • [34] Real-World Clinical Outcomes of First-Line (1L) Ibrutinib Dose Reduction Versus Acalabrutinib Among Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
    Shadman, Mazyar
    Karve, Sudeep
    Abbazio, Christopher
    Majd, Zahra
    Bacchus, Shaffee
    Saifan, Chadi
    Gogna, Priyanka
    Manceur, Ameur M.
    Lafeuille, Marie-Helene
    Emond, Bruno
    Srivastava, Bhavini P.
    Stephens, Deborah M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S352 - S352
  • [35] Real-world concordance of clinical practice with ASCO and NCCN guidelines for EGFR/ALK testing in aNSCLC.
    Ruggiero, John E.
    Rughani, Jay
    Neiman, Josh
    Swanson, Steven
    Revol, Cindy
    Green, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08)
  • [36] Real-World Treatment Patterns and Outcomes by Line of Therapy and Race in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated in the United States: Results From the Final Analysis of the Prospective, Observational, informCLL Registry
    Ghosh, Nilanjan
    Sharman, Jeff P.
    Gutierrez, Meghan
    Khan, Wasiulla
    Qureshi, Zaina P.
    Raz, Anat
    Girardi, Vincent
    Krigsfeld, Gabriel S.
    Barrientos, Jacqueline C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (09): : e301 - e313
  • [37] Hematologist/Oncologist Disease-Specific Expertise and Survival: Lessons from Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
    Shanafelt, Tait D.
    Kay, Neil E.
    Rabe, Kari G.
    Inwards, David J.
    Zent, Clive S.
    Leis, Jose F.
    Schwager, Susan M.
    Thompson, Carrie A.
    Bowen, Deborah A.
    Witzig, Thomas E.
    Slager, Susan L.
    Call, Timothy G.
    CANCER, 2012, 118 (07) : 1827 - 1837
  • [38] Real-World Treatment Switching and Sequencing to Next Line of Therapy of Zanubrutinib, Acalabrutinib, and Ibrutinib in Chronic/Small Lymphocytic Leukemia (CLL/SLL)
    Pinilla-Ibarz, Javier
    Xue, Mei
    Wu, Elizabeth
    Esselman, Kaitlyn
    Furnback, Wesley
    Challagulla, Swetha
    Yang, Keri
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S358 - S359
  • [39] Real-World Data from the Turkish National Chronic Lymphocytic Leukemia Registry
    Demirkan, Fatih
    Sevindik, Omur Gokmen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S229 - S229
  • [40] Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Shadman, Mazyar
    Salkar, Monika
    Srivastava, Bhavini
    Karve, Sudeep
    Emond, Bruno
    Gogna, Priyanka
    Manceur, Ameur M.
    Lafeuille, Marie-Helene
    Rava, Andrew
    Sun, Haiyan
    Howarth, Amanda
    Tomicki, Samantha
    Agatep, Barnabie
    Jones, Barton
    Franceschini, Erin
    Saifan, Chadi
    Bacchus, Shaffee
    Roeker, Lindsey
    Stephens, Deborah M.
    LEUKEMIA & LYMPHOMA, 2024,
12345